Polyunsaturated fatty acids in the low-birth-weight infant

Area of Science:

• Biochemistry
• Nutrition
• Pediatrics

Background:

• Essential fatty acids (EFAs) are polyunsaturated fatty acids (PUFAs) crucial for lipid incorporation and prostaglandin formation.
• EFAs influence biomembrane physicochemical characteristics and are conserved by the body, unlike nonessential PUFAs.
• Metabolic competition exists among EFAs, with more unsaturated fatty acids showing higher enzyme affinity.

Purpose of the Study:

• To review the essentiality, metabolism, and clinical significance of EFAs, particularly in infants.
• To explore the role of EFAs in fetal development and the effects of deficiency.
• To discuss EFA requirements, supplementation, and potential adverse effects of high intake.

Main Methods:

• Literature review of studies on EFA metabolism, function, and deficiency.
• Analysis of EFA transfer and metabolism during fetal development.
• Examination of clinical manifestations and treatment of EFA deficiency in infants.

Main Results:

• EFAs are essential for infant growth, fetal development, and proper utilization of saturated fatty acids.
• EFA deficiency in infants can lead to platelet dysfunction, reduced prostaglandin biosynthesis, and altered pulmonary surfactant.
• Maternal circulation provides EFAs to the fetus, with potential placental and fetal enzymatic modification.

Conclusions:

• Adequate EFA supply is critical for infant health, with deficiency causing significant clinical issues.
• While supplementation can alleviate deficiency symptoms, high linoleate intake may have adverse effects.
• Further research is needed on the long-term impacts of high dietary linoleate levels.